Literature DB >> 25632313

Cardiac magnetic resonance in clinical cardiology.

Andreas Kumar1, Rodrigo Bagur1.   

Abstract

Over the last decades, cardiac magnetic resonance (CMR) has transformed from a research tool to a widely used diagnostic method in clinical cardiology. This method can now make useful, unique contributions to the work-up of patients with ischemic and non-ischemic heart disease. Advantages of CMR, compared to other imaging methods, include very high resolution imaging with a spatial resolution up to 0.5 mm × 0.5 mm in plane, a large array of different imaging sequences to provide in vivo tissue characterization, and radiation-free imaging. The present manuscript highlights the relevance of CMR in the current clinical practice and new perspectives in cardiology.

Entities:  

Keywords:  Cardiac magnetic resonance; Cardiomyopathy; Gadolinium enhancement; Myocardial; Myocarditis

Year:  2015        PMID: 25632313      PMCID: PMC4306206          DOI: 10.4330/wjc.v7.i1.6

Source DB:  PubMed          Journal:  World J Cardiol


  36 in total

1.  Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection.

Authors:  Eric Larose; Helena Tizon-Marcos; Josep Rodés-Cabau; Stéphane Rinfret; Jean-Pierre Déry; Can M Nguyen; Onil Gleeton; Jean-Rock Boudreault; Louis Roy; Bernard Noël; Guy Proulx; Jacques Rouleau; Gérald Barbeau; Robert De Larochellière; Olivier F Bertrand
Journal:  Catheter Cardiovasc Interv       Date:  2010-10-01       Impact factor: 2.692

2.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

3.  MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial.

Authors:  Juerg Schwitter; Christian M Wacker; Norbert Wilke; Nidal Al-Saadi; Ekkehart Sauer; Kalman Huettle; Stefan O Schönberg; Andreas Luchner; Oliver Strohm; Hakan Ahlstrom; Thorsten Dill; Nadja Hoebel; Tamas Simor
Journal:  Eur Heart J       Date:  2012-03-04       Impact factor: 29.983

Review 4.  The emerging clinical role of cardiovascular magnetic resonance imaging.

Authors:  Andreas Kumar; David J Patton; Matthias G Friedrich
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

7.  Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR.

Authors:  Andreas Kumar; Jordin D Green; Jane M Sykes; Pinhas Ephrat; Jeffrey J L Carson; Andrea J Mitchell; Gerald Wisenberg; Matthias G Friedrich
Journal:  JACC Cardiovasc Imaging       Date:  2011-12

8.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

9.  Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.

Authors:  Theodoros D Karamitsos; Lucia Leccisotti; Jayanth R Arnold; Alejandro Recio-Mayoral; Paul Bhamra-Ariza; Ruairidh K Howells; Nick Searle; Matthew D Robson; Ornella E Rimoldi; Paolo G Camici; Stefan Neubauer; Joseph B Selvanayagam
Journal:  Circ Cardiovasc Imaging       Date:  2009-11-17       Impact factor: 7.792

10.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  4 in total

1.  Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction.

Authors:  Patrycja S Matusik; Amira Bryll; Paweł T Matusik; Tadeusz J Popiela
Journal:  Cardiol J       Date:  2020-02-10       Impact factor: 2.737

2.  Role of Cardiac MRI in the Assessment of Cardiomyopathy.

Authors:  Róisín B Morgan; Raymond Kwong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

Review 3.  Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?

Authors:  Elia De Maria; Annachiara Aldrovandi; Ambra Borghi; Letizia Modonesi; Stefano Cappelli
Journal:  World J Cardiol       Date:  2017-10-26

4.  Selected clinical parameters and changes in cardiac morphology and function assessed by magnetic resonance imaging in patients with rheumatoid arthritis and ankylosing spondylitis without clinically apparent heart disease.

Authors:  Wojciech Tański; Paweł Gać; Angelika Chachaj; Małgorzata Sobieszczańska; Rafał Poręba; Andrzej Szuba
Journal:  Clin Rheumatol       Date:  2021-06-26       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.